PMID- 30402863 OWN - NLM STAT- MEDLINE DCOM- 20191112 LR - 20210331 IS - 2284-0729 (Electronic) IS - 1128-3602 (Linking) VI - 22 IP - 20 DP - 2018 Oct TI - Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway. PG - 6965-6976 LID - 16167 [pii] LID - 10.26355/eurrev_201810_16167 [doi] AB - OBJECTIVE: MicroRNAs (miRNAs) are small single-stranded RNAs in eukaryotic cells, which play important regulatory roles in the pathogenesis of various diseases. We aimed to investigate the effects of miRNA-101 (miR-101) on hypoxia-induced myocardial infarction (MI) cell injury model (myocardial H9c2 cell injury model). The possible target gene of miR-101 was also analyzed. MATERIALS AND METHODS: H9c2 cells were exposed to hypoxia treatment. Cell viability, migration, invasion, apoptosis and the expression of miR-101 were detected using CCK-8 assay, transwell assay, flow cytometer analysis, Western blotting and qRT-PCR, respectively. Then, the effects of miR-101 overexpression or suppression on the cell injury induced by hypoxia were assessed. Dual luciferase reporter assay was used to analyze the possible target gene of miR-101. Finally, the effects of dimethyladenosine transferase 1 homolog (DIMT1), the possible target gene of miR-101, on H9c2 cell injury were investigated. RESULTS: Hypoxia significantly induced H9c2 cell injury. miR-101 was up-regulated after hypoxia induction. Hypoxia-induced cell injury was significantly reversed by miR-101 suppression and exacerbated by miR-101 overexpression. DIMT1 was a direct target gene of miR-101. Knockdown of DIMT1 markedly inhibited the protective effects of miR-101 suppression on hypoxia-induced cell injury by suppressing specific protein 1 (Sp1)/Survivin pathway. CONCLUSIONS: We verified the critical roles of miR-101 in regulating myocardial cell injury induced by hypoxia. DIMT1-mediated the Sp1/Survivin pathway was also involved in this process. Our findings replenished the understanding of the regulatory roles of miRNAs in hypoxia-induced MI cell injury and provided new molecular target for therapy and diagnosis of MI. FAU - Guo, Z-X AU - Guo ZX AD - Department of Cardiology, Taian City Central Hospital, Taian, China. zhanghuanyi0011@126.com. FAU - Zhou, F-Z AU - Zhou FZ FAU - Song, W AU - Song W FAU - Yu, L-L AU - Yu LL FAU - Yan, W-J AU - Yan WJ FAU - Yin, L-H AU - Yin LH FAU - Sang, H AU - Sang H FAU - Zhang, H-Y AU - Zhang HY LA - eng PT - Journal Article PT - Retracted Publication PL - Italy TA - Eur Rev Med Pharmacol Sci JT - European review for medical and pharmacological sciences JID - 9717360 RN - 0 (MIRN101 microRNA, rat) RN - 0 (MicroRNAs) RN - 0 (Sp1 Transcription Factor) RN - 0 (Survivin) RN - EC 2.- (Transferases) SB - IM RIN - Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):11986. PMID: 33336713 MH - Animals MH - Apoptosis/genetics MH - Cell Hypoxia/*genetics MH - Cell Line MH - Cell Survival/genetics MH - Hypoxia/metabolism MH - MicroRNAs/*genetics MH - Myocytes, Cardiac/metabolism MH - Rats MH - Signal Transduction MH - Sp1 Transcription Factor/*metabolism MH - Survivin/*metabolism MH - Transferases/genetics MH - Up-Regulation EDAT- 2018/11/08 06:00 MHDA- 2019/11/13 06:00 CRDT- 2018/11/08 06:00 PHST- 2018/11/08 06:00 [entrez] PHST- 2018/11/08 06:00 [pubmed] PHST- 2019/11/13 06:00 [medline] AID - 16167 [pii] AID - 10.26355/eurrev_201810_16167 [doi] PST - ppublish SO - Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):6965-6976. doi: 10.26355/eurrev_201810_16167.